The Client: Clare and Illingworth, renowned leaders in the field of optometry located in the UK.
The problem: The need to speed up the process of OCT interpretation and unburden the optometry team.
The Solution: Clare and Illingworth have embraced cutting-edge technology to enhance their Optical Coherence Tomography (OCT) analysis workflow. The introduction of Altris AI at this optometry center marks a significant milestone in their commitment to providing high-quality services to patients.
According to one of the owners of the optometry center, Richard, “We are adding a new OCT to one of our practices and will benefit from some extra support with AI to speed up the interpretation of results and assist the busy Optometry team.”
Altris AI, a leading provider of artificial intelligence solutions for healthcare, specializes in developing algorithms and software applications that augment medical imaging analysis. The integration of Altris AI into the British Optometry Center’s OCT workflow brings forth a host of advantages, revolutionizing the way eye conditions are diagnosed and managed.
FDA-cleared AI for OCT Analysis
Try it yourself in our Demo Account or get a Brochure
Technologies in Optometry and Ophthalmology: How AI Helps
One of the key benefits of Altris AI is its ability to automate and expedite the analysis of OCT scans. Traditionally, optometrists spent considerable time manually reviewing and interpreting OCT images.
FDA-cleared Altris AI is created to make the OCT workflow more effective
How does it work? Altris AI serves as a copilot, analyzing OCT scans in parallel to the eye care specialist. For instance, on this OCT scan, Altris AI detects Diffuse Edema, Floaters, Intraretinal Hyperreflective Foci, Posterior Hyaloid Membrane Detachment, RPE disruption, Shadowing, Hard Exudates, Intraretinal Cystoid Fluid.
- The classification in this case would be Diabetic Retinopathy.
With Altris AI, the process becomes significantly faster and more efficient. The AI algorithms can quickly analyze intricate details within the scans, providing clinicians with accurate and timely insights into the patient’s eye health.
Moreover, the use of Altris AI contributes to increased diagnostic accuracy. The algorithms are trained on vast datasets, learning to recognize subtle patterns and anomalies that may escape the human eye.
Thus, Altris AI recognizes 70+ retina pathologies and biomarkers, including DME, DR, GA, AMD, etc.
FDA-cleared AI for OCT Analysis
Try it yourself in our Demo Account or get a Brochure
Technologies in Optometry are paving the way to a new future where eye care specialists and AI will work together for better patient outcomes. AI will never be able to substitute eye care specialists because the final diagnosis must include clinical history, results of lab tests, and other diagnostic methods.